190 related articles for article (PubMed ID: 15007730)
1. Human topoisomerase I mediates illegitimate recombination leading to DNA insertion into the ribosomal DNA locus in Saccharomyces cerevisiae.
Zhu J; Schiestl RH
Mol Genet Genomics; 2004 Apr; 271(3):347-58. PubMed ID: 15007730
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae.
Zhu J; Schiestl RH
Mol Cell Biol; 1996 Apr; 16(4):1805-12. PubMed ID: 8657156
[TBL] [Abstract][Full Text] [Related]
3. Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II.
Christman MF; Dietrich FS; Fink GR
Cell; 1988 Nov; 55(3):413-25. PubMed ID: 2902925
[TBL] [Abstract][Full Text] [Related]
4. Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin.
Bjornsti MA; Knab AM; Benedetti P
Cancer Chemother Pharmacol; 1994; 34 Suppl():S1-5. PubMed ID: 8070016
[TBL] [Abstract][Full Text] [Related]
5. Effects of camptothecin or TOP1 overexpression on genetic stability in Saccharomyces cerevisiae.
Sloan R; Huang SN; Pommier Y; Jinks-Robertson S
DNA Repair (Amst); 2017 Nov; 59():69-75. PubMed ID: 28961461
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants.
Knab AM; Fertala J; Bjornsti MA
J Biol Chem; 1993 Oct; 268(30):22322-30. PubMed ID: 8226741
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.
Benedetti P; Fiorani P; Capuani L; Wang JC
Cancer Res; 1993 Sep; 53(18):4343-8. PubMed ID: 8395982
[TBL] [Abstract][Full Text] [Related]
8. A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings.
Kim RA; Wang JC
Cell; 1989 Jun; 57(6):975-85. PubMed ID: 2544296
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanism of DNA Topoisomerase I-Dependent rDNA Silencing: Sir2p Recruitment at Ribosomal Genes.
D'Alfonso A; Di Felice F; Carlini V; Wright CM; Hertz MI; Bjornsti MA; Camilloni G
J Mol Biol; 2016 Dec; 428(24 Pt B):4905-4916. PubMed ID: 27825925
[TBL] [Abstract][Full Text] [Related]
10. Gene conversion plays the major role in controlling the stability of large tandem repeats in yeast.
Gangloff S; Zou H; Rothstein R
EMBO J; 1996 Apr; 15(7):1715-25. PubMed ID: 8612596
[TBL] [Abstract][Full Text] [Related]
11. Enhanced CPT sensitivity of yeast cells and selective relaxation of Ga14 motif-containing DNA by novel Gal4-topoisomerase I fusion proteins.
Alessandri M; Beretta GL; Ferretti E; Mancia A; Khobta A; Capranico G
J Mol Biol; 2004 Mar; 337(2):295-305. PubMed ID: 15003448
[TBL] [Abstract][Full Text] [Related]
12. DNA topoisomerase-targeting antitumor drugs can be studied in yeast.
Nitiss J; Wang JC
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7501-5. PubMed ID: 2845409
[TBL] [Abstract][Full Text] [Related]
13. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin.
Bjornsti MA; Benedetti P; Viglianti GA; Wang JC
Cancer Res; 1989 Nov; 49(22):6318-23. PubMed ID: 2553253
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest.
Levin NA; Bjornsti MA; Fink GR
Genetics; 1993 Apr; 133(4):799-814. PubMed ID: 8385050
[TBL] [Abstract][Full Text] [Related]
15. Yeast systems for demonstrating the targets of anti-topoisomerase II agents.
Nitiss JL; Nitiss KC
Methods Mol Biol; 2001; 95():315-27. PubMed ID: 11089243
[No Abstract] [Full Text] [Related]
16. Regulation of rDNA stability by sumoylation.
Eckert-Boulet N; Lisby M
DNA Repair (Amst); 2009 Apr; 8(4):507-16. PubMed ID: 19261548
[TBL] [Abstract][Full Text] [Related]
17. Using yeast to understand drugs that target topoisomerases.
Nitiss JL; Rose A; Sykes KC; Harris J; Zhou J
Ann N Y Acad Sci; 1996 Dec; 803():32-43. PubMed ID: 8993498
[No Abstract] [Full Text] [Related]
18. Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiae.
Woo MH; Vance JR; Bjornsti MA
Methods Mol Biol; 2001; 95():303-13. PubMed ID: 11089242
[No Abstract] [Full Text] [Related]
19. Site-specific in vivo cleavages by DNA topoisomerase I in the regulatory regions of the 35 S rRNA in Saccharomyces cerevisiae are transcription independent.
Vogelauer M; Camilloni G
J Mol Biol; 1999 Oct; 293(1):19-28. PubMed ID: 10512712
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of topoisomerases affects transcription-dependent chromatin transitions in rDNA but not in a gene transcribed by RNA polymerase II.
Cavalli G; Bachmann D; Thoma F
EMBO J; 1996 Feb; 15(3):590-7. PubMed ID: 8599942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
